After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Recently, Yahoo Finance discussed the stock, revealing that Exelixis Announces Preliminary Fiscal Year 2023 Financial Results, Provides 2024 Financial Guidance, and Outlines Key Priorities and Milestones for 2024.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $22.54 and fluctuated between $22.63 as its day high and $22.31 as its day low. The current market capitalization of Exelixis Inc is $7.01B. A total of 1.51 million shares were traded on the day, compared to an average of 2.32M shares.
Insider Activity
Insider trades can also provide insight into a stock’s future direction. During the recent three months, EXEL has seen 1 BUY and 2 SELL insider trades, representing the acquisition of 116,893 and the disposition of 135,913 shares. Over the last 12 months, there were 35 BUYs and 46 SELLs from insiders. Insiders purchased 2,624,584 shares during that period but sold 1,472,498.
In the most recent transaction, Haley Patrick J. sold 50,000 shares of EXEL for 23.35 per share on Dec 14. After the transaction, the EVP, Commercial now owns 307,687 company shares. In a previous transaction on Dec 13, Hessekiel Jeffrey sold 25,000 shares at 23.01 per share. EXEL shares that EVP, General Counsel & Sec owns now total 533,345.
Among the insiders who sold shares, Haley Patrick J. disposed of 14,149 shares on Dec 12 at a per-share price of $22.50. This resulted in the EVP, Commercial holding 307,687 shares of EXEL after the transaction. In another insider transaction, Hessekiel Jeffrey sold 25,000 shares at $22.06 per share on Dec 04. Company shares held by the EVP, General Counsel & Sec now total 558,345.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for EXEL in the last 3 months, the mean price target is $26.53 with high estimates of $32.00 and low estimates of $18.00. In terms of 52-week highs and lows, EXEL has a high of $24.34 and a low of $16.15.
As of this writing, EXEL has an earnings estimate of $0.22 per share for the current quarter. EPS was calculated based on a consensus of 14 estimates, with a high estimate of $0.28 per share and a lower estimate of $0.05. The company reported an EPS of $0.25 in the last quarter, which was 56.20% higher than expectations of $0.16.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. EXEL’s latest balance sheet shows that the firm has $1.47B in Cash & Short Term Investments as of fiscal 2021. There were $51.27M in debt and $337.59M in liabilities at the time. Its Book Value Per Share was $7.55, while its Total Shareholder’s Equity was $2.21B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EXEL is Buy with a score of 4.61.
